Memantine in Adult Autism Spectrum Disorder

Stopped early · Not applicable · Has a placebo group

Conditions studied: Autism, Asperger's Disorder, Pervasive Developmental Disorder NOS

In brief

The purpose of this study is to see if memantine is helpful in managing problematic symptoms in adults with autism, Asperger's disorder, or Pervasive Developmental Disorder not otherwise specified (NOS).

Key facts

Study ID
NCT01078844
Run by
Johns Hopkins University
People needed
4
Starts
2010-02-01
Expected to finish
2010-07-01
Last updated by the study team
2017-07-26

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.